Browse drugs

…r and positive ENA, low C3 and C4 levels). She was treated with hydroxychloroquine (HCQ) 400 mg daily and a low dose of glucocorticoid for several…

…ade the patient sleep on the left hip. He had a therapy of 5 mg prednisone, vitamins B12 and D, a proton-pump inhibitor, and topical eye d…

…aseline, 60% received oral GC (median dose 10 [10–15] mg/day of prednisolone equivalent), 55% aminoquinoline drugs, and 10% other immunosuppressants. I…

… frequently experience inadequate responses to glucocorticoids (GC) and immunosuppressants (IS), leading to refractory disease and…

…, urinary casts, and pyuria versus patients without visits with SLEDAI >8. Low complement and high DNA binding were common irrespectiv…

…gue, and more frequent use of antidepressants, anxiolytics, and oral corticosteroids (all p < 0.001). Educational attainment correlated with functio…

…ected. Forty-eight patients received B-cell targeted therapies (belimumab 40=; rituximab n=8). For these, treatment duration, reasons for…

…r 12 months for subacute SLE and had a complete renal response. Anifrolumab was added to her. A complete renal response had 4 of the 11 pat…

… median SLEDAI-2K score was 4 (2-6), and 51.7% of patients used prednisone (table 2). Low C3/C4 and anti-dsDNA positivity were present in …

… 4.0 (https://creativecommons.org/licenses/by/4.0/).Conclusions Anifrolumab demonstrates consistent efficacy across CLE subtypes, and an ac…

… associated with earlier flare occurrence (log-rank p = 0.002). Hydroxychloroquine (HCQ) tapering or discontinuation invariably preceded moderate-…

…nts were taking a mean of 2.2 SLE medications; 98% had received hydroxychloroquine and 80% at least one immunosuppressant (including biologics). C…